A familial case of DICER1 syndrome in a patient with pleuropulmonary blastoma

Cover Page

Cite item

Full Text

Abstract

Pleuropulmonary blastoma (PPB) is a very rare tumor of childhood that arises from the mesenchyme of the lung and is associated with mutations in the DICER1 gene. The present article describes a familial case of DICER1 syndrome in a patient aged 3 years and 11 months who underwent investigations and treatment for type II/III PPB of the lower lobe of the left lung at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation. The patient's parents gave their consent to the use of their child's data, including photographs, for research purposes and in publications. The diagnosis was made based on the results of the pathology investigation of the tissue obtained by open biopsy. Furthermore, the diagnosis was confirmed by the review of histological specimens in the International PPB Registry (Minneapolis, USA). According to the data from the chest CT with intravenous contrast enhancement, the tumor was described as a mass consisting of cystic cavities of various calibers accumulating a contrast agent along the periphery, and a solid component. Specific combination treatment was based on the recommendations of the International PPB Registry and included chemotherapy according to the IVADo/IVA regimen and surgical treatment as a local control. Currently, specific treatment has been completed, the patient is alive with no signs of the disease, the follow-up period was 20 months. As regards the patient's family history, he has a sibling (older brother) who was diagnosed with a cystic nephroma at the age of 1 year and 4 months. Molecular genetic testing of the tumor tissues obtained from the patient (PPB) and his sibling (cystic nephroma) revealed pathogenic somatic variants in the DICER1 gene. Along with the somatic genetic variants, another pathogenic variant was found in both children, the germline status of which was confirmed. The germline variant in the DICER1 gene was inherited from the mother. Thus, the investigations confirmed a familial case of DICER1 syndrome. The case described in this article indicates that families in which DICER1 syndrome was found require special management aimed at early detection of tumors and non-tumor conditions associated with this syndrome in the carriers of pathogenic alleles.

About the authors

M. V. Teleshova

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: teleshova_m@mail.ru
ORCID iD: 0000-0003-4042-0125

a pediatric oncologist of the Department of Clinical Oncology

Russian Federation, 117997, Moscow, Samory Mashela St., 1

L. A. Yasko

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Email: teleshova_m@mail.ru
ORCID iD: 0000-0003-3007-3772

Moscow

Russian Federation

E. V. Maslenkova

N.I. Pirogov Russian National Research Medical University of Ministry of Healthcare of the Russian Federation

Email: teleshova_m@mail.ru
ORCID iD: 0000-0001-6818-4027

Moscow

Russian Federation

N. N. Merkulov

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Email: teleshova_m@mail.ru
ORCID iD: 0000-0003-0404-6420

Moscow

Russian Federation

D. M. Konovalov

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Email: teleshova_m@mail.ru
ORCID iD: 0000-0001-7732-8184

Moscow

Russian Federation

M. A. Kurnikova

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Email: teleshova_m@mail.ru
ORCID iD: 0000-0003-0900-6874

Moscow

Russian Federation

I. V. Doronina

Murmansk Regional Children's Clinical Hospital

Email: teleshova_m@mail.ru

Murmansk

Russian Federation

T. V. Shamanskaya

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Email: teleshova_m@mail.ru
ORCID iD: 0000-0002-3767-4477

Moscow

Russian Federation

D. Yu. Kachanov

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0002-3704-8783

Moscow

Russian Federation

References

  1. Manivel J.C., Priest J.R., Watterson J., Steiner M., Woods W.G., Wick M.R., et al. Pleuropulmonary blastoma. The so-called pulmonary blastoma of childhood. Cancer. 1988; 62 (8): 1516–26. doi: 10.1002/1097-0142(19881015)62:8<1516::aid-cncr2820620812>3.0.co;2-3
  2. Dishop M.K., Kuruvilla S. Primary and metastatic lung tumors in the pediatric population: a review and 25-year experience at a large children's hospital. Arch Pathol Lab Med 2008; 132 (7): 1079–103. doi: 10.5858/2008-132-1079-PAMLTI
  3. Schultz K.A.P., Williams G.M., Kamihara J., Stewart D.R., Harris A.K., Bauer A.J., et al. DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies. Clin Cancer Res 2018; 24 (10): 2251–61. doi: 10.1158/1078-0432.CCR-17-3089
  4. Schultz K.A.P., Stewart D.R., Kamihara J., Bauer A.J., Merideth M.A., Stratton P., et al. DICER1 Tumor Predisposition. 2014 Apr 24 [updated 2020 Apr 30]. In: Adam M.P., Mirzaa G.M., Pagon R.A., Wallace S.E., Bean L.J.H., Gripp K.W., Amemiya A. (eds.). GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022.
  5. Messinger Y.H., Stewart D.R., Priest J.R., Williams G.M., Harris A.K., Schultz K.A.P., et al. Pleuropulmonary blastoma: a report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry. Cancer 2015; 121 (2): 276–85. doi: 10.1002/cncr.29032
  6. Caroleo A.M., De Ioris M.A., Boccuto L., Alessi I., Del Baldo G., Cacchione A., et al. DICER1 Syndrome and Cancer Predisposition: From a Rare Pediatric Tumor to Lifetime Risk. Front Oncol 2021; 10: 614541. doi: 10.3389/fonc.2020.614541
  7. Hill D.A., Jarzembowski J.A., Priest J.R., Williams G.M., Schoettler P., Dehner L.P. Type I pleuropulmonary blastoma: pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry. Am J Surg Pathol 2008; 32 (2): 282–95. doi: 10.1097/PAS.0b013e3181484165
  8. Bisogno G., Brennan B., Orbach D., Stachowicz-Stencel T., Cecchetto G., Indolfi P., et al. Treatment and prognostic factors in pleuropulmonary blastoma: an EXPeRT report. Eur J Cancer 2014; 50 (1): 178–84. doi: 10.1016/j.ejca.2013.08.015
  9. Priest J.R., Magnuson J., Williams G.M., Abromowitch M., Byrd R., Sprinz P., et al. Cerebral metastasis and other central nervous system complications of pleuropulmonary blastoma. Pediatr Blood Cancer 2007; 49 (3): 266–73. doi: 10.1002/pbc.20937
  10. Bisogno G., Sarnacki S., Stachowicz-Stencel T., Minard Colin V., Ferrari A., Godzinski J., et al. Pleuropulmonary blastoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations. Pediatr Blood Cancer 2021; 68 Suppl 4: e29045. doi: 10.1002/pbc.29045
  11. Sparber-Sauer M., Tagarelli A., Seitz G., Sorg B., Bien E., Bel-Ami T., et al. Children with progressive and relapsed pleuropulmonary blastoma: A European collaborative analysis. Pediatr Blood Cancer 2021; 68 (12): e29268. doi: 10.1002/pbc.29268
  12. Priest J.R., Watterson J., Strong L., Huff V., Woods W.G., Byrd R.L., et al. Pleuropulmonary blastoma: a marker for familial disease. J Pediatr 1996; 128 (2): 220–4. doi: 10.1016/s0022-3476(96)70393-1
  13. Hill D.A., Ivanovich J., Priest J.R., Gurnett C.A., Dehner L.P., Desruisseau D., et al. DICER1 mutations in familial pleuropulmonary blastoma. Science 2009; 325 (5943): 965. doi: 10.1126/science.1174334
  14. Robertson J.C., Jorcyk C.L., Oxford J.T. DICER1 Syndrome: DICER1 Mutations in Rare Cancers. Cancers (Basel) 2018; 10 (5): 143. doi: 10.3390/cancers10050143
  15. Brenneman M., Field A., Yang J., Williams G., Doros L., Rossi C., et al. Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in DICER1 syndrome: a unique variant of the two-hit tumor suppression model. F1000Res 2015; 4: 214. doi: 10.12688/f1000research.6746.2
  16. Kim J., Amanda F., Schultz K.A.P., Hill D.A., Stewart D.R. The prevalence of DICER1 pathogenic variation in population databases. Int J Cancer 2017; 141 (10): 2030–6. doi: 10.1002/ijc.30907
  17. Шульц К.Э.П., Вилльямс Г.М., Качанов Д.Ю., Варфоломеева С.Р., Хилл Э.Д., Денер Л.П. и соавт. DICER1-синдром и плевропульмональная бластома: отчет Международного регистра плевропульмональной бластомы. Российский журнал детской гематологии и онкологии 2017; 4 (4): 9–19. doi: 10.17650/2311-1267-2017-4-4-13-19
  18. Doros L.A., Rossi C.T., Yang J., Field A., Williams G.M., Messinger Y., et al. DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma. Mod Pathol 2014; 27 (9): 1267–80. doi: 10.1038/modpathol.2013.242
  19. Stewart D.R., Best A.F., Williams G.M., Harney L.A., Carr A.G., Harris A.K., et al. Neoplasm Risk Among Individuals with a Pathogenic Germline Variant in DICER1. J Clin Oncol 2019; 37 (8): 668–76. doi: 10.1200/JCO.2018.78.4678
  20. Kantor N., Wayne C., Nasr A. Symptom development in originally asymptomatic CPAM diagnosed prenatally: a systematic review. Pediatr Surg Int 2018; 34 (6): 613–20. doi: 10.1007/s00383-018-4264-y
  21. Feinberg A., Hall N.J., Williams G.M., Schultz K.A.P., Miniati D., Hill D.A., et al. Can congenital pulmonary airway malformation be distinguished from Type I pleuropulmonary blastoma based on clinical and radiological features? J Pediatr Surg 2016; 51 (1): 33–7. doi: 10.1016/j.jpedsurg.2015.10.019

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2022 Teleshova M.V., Yasko L.A., Maslenkova E.V., Merkulov N.N., Konovalov D.M., Kurnikova M.A., Doronina I.V., Shamanskaya T.V., Kachanov D.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.